Skip to main content

Bristol-Myers Squibb

Bristol-Myers Squibb is an American biopharmaceutical company engaged in the research, development, manufacture, and delivery of specialized human prescription medicines. The company focuses its research and commercial divisions on core therapeutic areas including oncology, hematology, cardiovascular disease, and immunology. Its biopharmaceutical product lineup features major commercial therapeutics such as Eliquis, Opdivo, Revlimid, Pomalyst, and Yervoy. Revenue is driven by global wholesale distribution of proprietary pharmaceuticals to drug wholesalers, retail pharmacy chains, and medical institutions. Bristol-Myers Squibb maintains a leading global market position in immuno-oncology treatments and oral anticoagulant therapies. The company is headquartered in Princeton, New Jersey, and its common stock is traded on the New York Stock Exchange under ticker symbol BMY.

129 of the funds FundTelligence covers report a position in Bristol-Myers Squibb.

Legal name
Bristol-Myers Squibb Co
Sector
Health Care
Country
United States
Funds holding it
129

Funds holding Bristol-Myers Squibb

Showing the 8 largest of 129 funds holding it.

Loading...